Literature DB >> 17920205

Mesencephalic dopamine neuron number and tyrosine hydroxylase content: Genetic control and candidate genes.

C Vadasz1, J F Smiley, K Figarsky, M Saito, R Toth, B M Gyetvai, M Oros, K K Kovacs, P Mohan, R Wang.   

Abstract

The mesotelencephalic dopamine system shows substantial genetic variation which fundamentally affects normal and pathological behaviors related to motor function, motivation, and learning. Our earlier radioenzyme assay studies demonstrated significantly higher activity of tyrosine hydroxylase (TH), the first and rate limiting enzyme in the biosynthesis of catecholamine neurotransmitters, in the substantia nigra-ventral tegmental area of BALB/cJ mice in comparison with that of C57BL/6ByJ mice. Here, using quantitative immunoblotting and immunocytochemistry, we tested the hypothesis that mesencephalic TH protein content and number of nigral TH-positive neurons show strain-dependent differences in C57BL/6ByJ and BALB/cJ parallel to those observed in the TH activity studies. Immunoblotting experiments detected significantly higher mesencephalic TH protein content in BALB/cJ in comparison to C57BL/6ByJ (P<0.05). Immunocytochemical studies demonstrated that the number of TH-positive cells in substantia nigra was 31.3% higher in BALB/cJ than that in C57BL/6ByJ (P<0.01), while the average dopamine neuron volume was not significantly different. In a search for candidate genes that modulate TH content and the size of mesencephalic dopamine neuron populations we also studied near-isogenic mouse sublines derived from the C57BL/6ByJ and BALB/cJ progenitor strains. A whole-genome scan with 768 single nucleotide polymorphism markers indicated that two sublines, C4A6/N and C4A6/B, were genetically very similar (98.3%). We found significantly higher mesencephalic TH protein content in C4A6/B in comparison to C4A6/N (P=0.01), and a tendency for higher number of dopamine neurons in the substantia nigra in C4A6/B in comparison to C4A6/N, which, however, did not reach statistical significance. To identify the genetic source of the TH content difference we analyzed the single nucleotide polymorphism (SNP) genotype data of the whole-genome scan, and detected two small differential chromosome segments on chr. 13 and chr. 14. Microarray gene expression studies and bioinformatic analysis of the two differential regions implicated two cis-regulated genes (Spock1 and Cxcl14, chr. 13), and two growth factor genes [bone morphogenetic protein 6 (Bmp6) (chr. 13), and fibroblast growth factor 14 (Fgf14) (chr. 14)]. Taken together, the results suggest that (1) nigral dopamine neuron number and TH protein content may be genetically associated but further studies are needed to establish unequivocally this linkage, and (2) Spock1, Cxcl14, Bmp6, and Fgf14 are novel candidates for modulating the expression and maintenance of TH content in mesencephalic dopamine neurons in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920205      PMCID: PMC2128036          DOI: 10.1016/j.neuroscience.2007.06.049

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  42 in total

1.  Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits.

Authors:  Margarete Mehrabian; Hooman Allayee; Jirina Stockton; Pek Yee Lum; Thomas A Drake; Lawrence W Castellani; Michael Suh; Christopher Armour; Stephen Edwards; John Lamb; Aldons J Lusis; Eric E Schadt
Journal:  Nat Genet       Date:  2005-10-02       Impact factor: 38.330

2.  Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator.

Authors:  M J West; L Slomianka; H J Gundersen
Journal:  Anat Rec       Date:  1991-12

3.  Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'.

Authors:  Leonid Bystrykh; Ellen Weersing; Bert Dontje; Sue Sutton; Mathew T Pletcher; Tim Wiltshire; Andrew I Su; Edo Vellenga; Jintao Wang; Kenneth F Manly; Lu Lu; Elissa J Chesler; Rudi Alberts; Ritsert C Jansen; Robert W Williams; Michael P Cooke; Gerald de Haan
Journal:  Nat Genet       Date:  2005-02-13       Impact factor: 38.330

4.  Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14.

Authors:  Q Wang; D G McEwen; D M Ornitz
Journal:  Mech Dev       Date:  2000-02       Impact factor: 1.882

5.  Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo.

Authors:  Galina V Shurin; Robert L Ferris; Robert Ferris; Irina L Tourkova; Lori Perez; Anna Lokshin; Levent Balkir; Bobby Collins; Gurkamal S Chatta; Michael R Shurin
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

6.  Bone morphogenetic protein-6 is a neurotrophic factor for calbindin-positive striatal neurons.

Authors:  E Gratacòs; N Gavaldà; J Alberch
Journal:  J Neurosci Res       Date:  2002-12-01       Impact factor: 4.164

7.  Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels.

Authors:  Jun-Yang Lou; Fernanda Laezza; Benjamin R Gerber; Maolei Xiao; Kathryn A Yamada; Hali Hartmann; Ann Marie Craig; Jeanne M Nerbonne; David M Ornitz
Journal:  J Physiol       Date:  2005-09-15       Impact factor: 5.182

8.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

9.  Bone morphogenetic proteins but not growth differentiation factors induce dopaminergic differentiation in mesencephalic precursors.

Authors:  A Brederlau; R Faigle; P Kaplan; P Odin; K Funa
Journal:  Mol Cell Neurosci       Date:  2002-11       Impact factor: 4.314

10.  BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells.

Authors:  Thomas D Shellenberger; Mary Wang; Manu Gujrati; Arumugam Jayakumar; Robert M Strieter; Marie D Burdick; Constantin G Ioannides; Clayton L Efferson; Adel K El-Naggar; Dianna Roberts; Gary L Clayman; Mitchell J Frederick
Journal:  Cancer Res       Date:  2004-11-15       Impact factor: 12.701

View more
  18 in total

1.  The chemokine BRAK/CXCL14 regulates synaptic transmission in the adult mouse dentate gyrus stem cell niche.

Authors:  Ghazal Banisadr; Bula J Bhattacharyya; Abdelhak Belmadani; Sarah C Izen; Dongjun Ren; Phuong B Tran; Richard J Miller
Journal:  J Neurochem       Date:  2011-11-02       Impact factor: 5.372

2.  A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse.

Authors:  Z C Baquet; D Williams; J Brody; R J Smeyne
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

3.  Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.

Authors:  D J Vidyadhara; H Yarreiphang; T R Raju; Phalguni Anand Alladi
Journal:  Mol Neurobiol       Date:  2016-10-04       Impact factor: 5.590

4.  Microarray-assisted fine mapping of quantitative trait loci on chromosome 15 for susceptibility to seizure-induced cell death in mice.

Authors:  P E Schauwecker
Journal:  Eur J Neurosci       Date:  2013-09-03       Impact factor: 3.386

5.  Functional Modulation of Voltage-Gated Sodium Channels by a FGF14-Based Peptidomimetic.

Authors:  Syed R Ali; Zhiqing Liu; Miroslav N Nenov; Oluwarotimi Folorunso; Aditya Singh; Federico Scala; Haiying Chen; T F James; Musaad Alshammari; Neli I Panova-Elektronova; Mark Andrew White; Jia Zhou; Fernanda Laezza
Journal:  ACS Chem Neurosci       Date:  2018-02-06       Impact factor: 4.418

Review 6.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Selective reduction of cerebral cortex GABA neurons in a late gestation model of fetal alcohol spectrum disorder.

Authors:  John F Smiley; Mariko Saito; Cynthia Bleiwas; Kurt Masiello; Babak Ardekani; David N Guilfoyle; Scott Gerum; Donald A Wilson; Csaba Vadasz
Journal:  Alcohol       Date:  2015-07-21       Impact factor: 2.405

Review 8.  Developmental changes in dopamine neurotransmission in adolescence: behavioral implications and issues in assessment.

Authors:  Dustin Wahlstrom; Paul Collins; Tonya White; Monica Luciana
Journal:  Brain Cogn       Date:  2009-11-26       Impact factor: 2.310

9.  Strain commonalities and differences in response-outcome decision making in mice.

Authors:  Kelsey S Zimmermann; Chia-Chun Hsu; Shannon L Gourley
Journal:  Neurobiol Learn Mem       Date:  2016-03-18       Impact factor: 2.877

10.  Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo.

Authors:  Christoph D Schmid; Benoit Melchior; Kokoechat Masek; Shweta S Puntambekar; Patria E Danielson; David D Lo; J Gregor Sutcliffe; Monica J Carson
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.